Print

Cambrex Corporation (CBM) to Present at Wells Fargo 2013 Healthcare Conference  
6/12/2013 7:27:09 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

EAST RUTHERFORD, N.J., June 12, 2013 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that Steven Klosk, President and Chief Executive Officer, will make a presentation on the Company at the Wells Fargo 2013 Healthcare Conference on June 19, 2013 at 9:30 a.m. EDT.

The live audio webcast and slide presentation can be accessed from the Cambrex website at www.cambrex.com in the Investors section under "Webcasts & Presentations", and a replay will be available for 90 days after the live event concludes.

About Cambrex
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The Company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit http://www.cambrex.com/.

SOURCE Cambrex Corporation



Help employers find you! Check out all the jobs and post your resume.

//-->